진단용 방사성 동위원소 시장 : 방사성 동위원소별, 용도별, 영상진단법별, 최종사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율 및 예측(2024-2032년)

REPORT HIGHLIGHT

Diagnostic Radioisotopes Market size was valued at USD 5,820.21 Million in 2023, expanding at a CAGR of 9.81% from 2024 to 2032.

Diagnostic radioisotopes are radioactive isotopes that are employed in medical imaging for the purpose of diagnosing various medical conditions and diseases. These particular radioisotopes emit gamma rays, which can be detected by specialized imaging equipment like gamma cameras or PET scanners. The administration of these radioisotopes to patients is typically done through oral ingestion, intravenous injection, or inhalation, depending on the specific imaging procedure and the organ or tissue under examination. Despite their radioactive nature, the doses utilized in diagnostic imaging are extremely small and are considered safe for patients. In fact, the advantages of diagnostic imaging with radioisotopes often outweigh the potential risks associated with radiation exposure.

Diagnostic Radioisotopes Market- Market Dynamics

Rising Prevalence of Chronic Diseases is anticipated to propel the market growth

Chronic illnesses like cancer, heart diseases, and neurological disorders often necessitate frequent diagnostic imaging for monitoring disease progression, evaluating treatment effectiveness, and identifying recurrence. Diagnostic radioisotopes are essential in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma camera imaging, facilitating precise diagnosis and staging of chronic illnesses. According to the U.S. National Center for Health Statistics, a chronic disease is one that lasts for three months or more. Approximately 40 million Americans have limitations in their daily activities due to one or more chronic health conditions. The increasing adoption of hybrid imaging technologies presents a growth opportunity for the market. However, the high cost of production and infrastructure may hinder market growth.

Diagnostic Radioisotopes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.81% over the forecast period (2024-2032)

Based on Radioisotope segmentation, Technetium-99m was predicted to show maximum market share in the year 2023

Based on application segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Diagnostic Radioisotopes Market- Segmentation Analysis:

The Global Diagnostic Radioisotopes Market is segmented on the basis of Radioisotope, Application, Imaging Modality, End-user and Region.

The market is segmented into five divisions according to Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others. Technetium-99m holds the largest share in the market. Technetium-99m (Tc-99m) is a highly utilized radioisotope in nuclear medicine for diagnostic imaging.

The market is segmented into two categories according to application: Oncology, Cardiology, and Other. Oncology holds the largest share in the market. Diagnostic radioisotopes are crucial in different imaging techniques utilized in oncology, assisting in tumor detection and characterization, disease progression assessment, and treatment response evaluation.

The market is segmented into three categories according to Imaging Modality: SPECT, PET, and Beta Emitters. Each imaging modality uses distinct radioisotopes to observe biological processes and structures in the body, aiding in the diagnosis, staging, treatment planning, and monitoring of different diseases, such as cancer.

The market is segmented into four categories according to End-user: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Other establishments. Each end-user group has unique needs and demands for diagnostic imaging services that make use of radioisotopes.

Diagnostic Radioisotopes Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be driven by North America, primarily due to increasing investments in nuclear medicine. The Tympanostomy Products market mainly focuses on the treatment of ear infections and related otolaryngology procedures, while nuclear medicine is centered around medical imaging and diagnosis using radioisotopes. In the United States, there are over 20 million nuclear medicine procedures conducted annually, while in Europe, the number is around 10 million, with 2 million of them being therapeutic procedures. Looking ahead, Europe is projected to be the driving force behind the market's growth, mainly due to advancements in diagnostic imaging modalities.

Diagnostic Radioisotopes Market- Competitive Landscape:

The Diagnostic Radioisotopes Market is characterized by intense competition, with companies striving to ensure a steady and dependable supply of high-quality radioisotopes. They also focus on providing efficient imaging solutions, adhering to safety and regulatory guidelines, and fostering innovation to meet the evolving needs of healthcare professionals and patients. Additionally, competition in this market revolves around the quality, reliability, and variety of radioisotope products offered by radio pharmaceutical companies. Technological advancements are also pursued to improve production efficiency, lower costs, and ensure compliance with safety and regulatory standards.

Recent Developments:

Siemens Healthineers has announced its decision to close down its Fast Track Diagnostics unit, a division within the Diagnostics business that offers polymerase chain reaction (PCR) testing products. This particular portfolio is primarily sold in Europe. The demand for these products has significantly declined since the peak of the COVID-19 pandemic.

Another advancement in medical imaging is positron emission tomography (PET), a highly accurate and advanced technique that utilizes isotopes generated in a cyclotron. By introducing a positron-emitting radionuclide, typically through injection, it accumulates in the specific tissue being targeted.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GE Healthcare

Siemens Healthineers

Koninklijke Philips N.V.

Cardinal Health

Lantheus Holdings, Inc.

Bayer AG

Bracco

Eckert & Ziegler

Nordion (Canada) Inc.

NTP Radioisotopes

Curium, Jubilant Life Sciences Ltd

Isotopia Molecular Imaging Ltd.

Mallinckrodt Nuclear Medicine LLC

Jubilant DraxImage Inc.

Sumitomo Heavy Industries, Ltd.

Telix Pharmaceuticals Limited

Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY RADIOISOTOPE- MARKET ANALYSIS, 2019 - 2032

• Technetium-99m
• Thallium-201
• Gallium-67
• Iodine-123
• FDG
• Rubidium-82
• Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Oncology
• Cardiology
• Other

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY IMAGING MODALITY- MARKET ANALYSIS, 2019 - 2032

• SPECT
• PET
• Beta Emitters

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Academic & Research Institutes
• Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Diagnostic Radioisotopes Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Diagnostic Radioisotopes Market Snippet by Radioisotope
  • 2.1.2.Diagnostic Radioisotopes Market Snippet by Application
  • 2.1.3.Diagnostic Radioisotopes Market Snippet by Imaging Modality
  • 2.1.4.Diagnostic Radioisotopes Market Snippet by End-User
  • 2.1.5.Diagnostic Radioisotopes Market Snippet by Country
  • 2.1.6.Diagnostic Radioisotopes Market Snippet by Region
• 2.2.Competitive Insights

3.Diagnostic Radioisotopes Key Market Trends

• 3.1.Diagnostic Radioisotopes Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Diagnostic Radioisotopes Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Diagnostic Radioisotopes Market Opportunities
• 3.4.Diagnostic Radioisotopes Market Future Trends

4.Diagnostic Radioisotopes Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Diagnostic Radioisotopes Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Diagnostic Radioisotopes Market Landscape

• 6.1.Diagnostic Radioisotopes Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Diagnostic Radioisotopes Market - By Radioisotope

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Radioisotope, 2023 & 2032 (%)
  • 7.1.2.Technetium-99m
  • 7.1.3.Thallium-201
  • 7.1.4.Gallium-67
  • 7.1.5.Iodine-123
  • 7.1.6.FDG
  • 7.1.7.Rubidium-82
  • 7.1.8.Others

8.Diagnostic Radioisotopes Market - By Application

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2.Oncology
  • 8.1.3.Cardiology
  • 8.1.4.Other

9.Diagnostic Radioisotopes Market - By Imaging Modality

• 9.1.Overview
  • 9.1.1.Segment Share Analysis, By Imaging Modality, 2023 & 2032 (%)
  • 9.1.2.SPECT
  • 9.1.3.PET
  • 9.1.4.Beta Emitters

10.Diagnostic Radioisotopes Market - By End-User

• 10.1.Overview
  • 10.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
  • 10.1.2.Hospitals
  • 10.1.3.Specialty Clinics
  • 10.1.4.Diagnostic Centers
  • 10.1.5.Academic & Research Institutes
  • 10.1.6.Others

11.Diagnostic Radioisotopes Market- By Geography

• 11.1.Introduction
  • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 11.2.North America
  • 11.2.1.Overview
  • 11.2.2.Diagnostic Radioisotopes Key Manufacturers in North America
  • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4.North America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
  • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.2.6.North America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 11.2.7.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.2.8.U.S.
    • 11.2.8.1.Overview
    • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3.U.S. Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.5.U.S. Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.2.8.6.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.2.9.Canada
    • 11.2.9.1.Overview
    • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3.Canada Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.5.Canada Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.2.9.6.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.3.Europe
  • 11.3.1.Overview
  • 11.3.2.Diagnostic Radioisotopes Key Manufacturers in Europe
  • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4.Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
  • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.6.Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 11.3.7.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.8.Germany
    • 11.3.8.1.Overview
    • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3.Germany Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.5.Germany Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.8.6.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.9.Italy
    • 11.3.9.1.Overview
    • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3.Italy Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.5.Italy Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.9.6.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.10.United Kingdom
    • 11.3.10.1.Overview
    • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3.United Kingdom Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.5.United Kingdom Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.10.6.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.11.France
    • 11.3.11.1.Overview
    • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3.France Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.5.France Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.11.6.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.12.Russia
    • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.2.Russia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.4.Russia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.12.5.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.13.Netherlands
    • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.2.Netherlands Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.4.Netherlands Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.13.5.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.14.Sweden
    • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.2.Sweden Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.4.Sweden Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.14.5.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.15.Poland
    • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.2.Poland Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.4.Poland Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.15.5.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.16.Rest of Europe
    • 11.3.16.1.Overview
    • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.4.Asia Pacific (APAC)
  • 11.4.1.Overview
  • 11.4.2.Diagnostic Radioisotopes Key Manufacturers in Asia Pacific
  • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4.Asia Pacific Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
  • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.6.Asia Pacific Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 11.4.7.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.8.India
    • 11.4.8.1.Overview
    • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3.India Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.5.India Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.8.6.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.9.China
    • 11.4.9.1.Overview
    • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3.China Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.5.China Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.9.6.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.10.Japan
    • 11.4.10.1.Overview
    • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3.Japan Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.5.Japan Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.10.6.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.11.South Korea
    • 11.4.11.1.Overview
    • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3.South Korea Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.5.South Korea Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.11.6.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.12.Australia
    • 11.4.12.1.Overview
    • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3.Australia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.5.Australia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.12.6.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.13.Thailand
    • 11.4.13.1.Overview
    • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3.Thailand Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.5.Thailand Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.13.6.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.14.Indonesia
    • 11.4.14.1.Overview
    • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3.Indonesia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.5.Indonesia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.14.6.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.15.Philippines
    • 11.4.15.1.Overview
    • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3.Philippines Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.5.Philippines Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.15.6.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.16.Rest of APAC
    • 11.4.16.1.Overview
    • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3.Rest of APAC Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.5.Rest of APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.16.6.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.5.Latin America
  • 11.5.1.Overview
  • 11.5.2.Diagnostic Radioisotopes Key Manufacturers in Latin America
  • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4.Latin America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
  • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.6.Latin America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 11.5.7.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.8.Brazil
    • 11.5.8.1.Overview
    • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3.Brazil Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.5.Brazil Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.5.8.6.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.9.Mexico
    • 11.5.9.1.Overview
    • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3.Mexico Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.5.Mexico Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.5.9.6.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.10.Argentina
    • 11.5.10.1.Overview
    • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3.Argentina Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.5.Argentina Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.5.10.6.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.11.Colombia
    • 11.5.11.1.Overview
    • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3.Colombia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.5.Colombia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.5.11.6.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.12.Rest of LATAM
    • 11.5.12.1.Overview
    • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.6.Middle East and Africa
  • 11.6.1.Overview
  • 11.6.2.Diagnostic Radioisotopes Key Manufacturers in Middle East and Africa
  • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4.Middle East and Africa Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
  • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.6.Middle East and Africa Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 11.6.7.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.8.Saudi Arabia
    • 11.6.8.1.Overview
    • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.9.United Arab Emirates
    • 11.6.9.1.Overview
    • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.10.Israel
    • 11.6.10.1.Overview
    • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3.Israel Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.5.Israel Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.10.6.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.11.Turkey
    • 11.6.11.1.Overview
    • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3.Turkey Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.5.Turkey Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.11.6.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.12.Algeria
    • 11.6.12.1.Overview
    • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3.Algeria Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.5.Algeria Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.12.6.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.13.Egypt
    • 11.6.13.1.Overview
    • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3.Egypt Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.5.Egypt Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.13.6.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.14.Rest of MEA
    • 11.6.14.1.Overview
    • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3.Rest of MEA Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.5.Rest of MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.14.6.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Diagnostic Radioisotopes Industry

• 12.1.Competitive Dashboard
• 12.2.Company Profiles
  • 12.2.1.GE Healthcare
  • 12.2.2.Siemens Healthineers
  • 12.2.3.Koninklijke Philips N.V.
  • 12.2.4.Cardinal Health
  • 12.2.5. Lantheus Holdings, Inc.
  • 12.2.6.Bayer AG
  • 12.2.7.Bracco
  • 12.2.8. Eckert & Ziegler
  • 12.2.9.Nordion (Canada) Inc.
  • 12.2.10.NTP Radioisotopes
  • 12.2.11.Curium, Jubilant Life Sciences Ltd
  • 12.2.12.Isotopia Molecular Imaging Ltd.
  • 12.2.13.Mallinckrodt Nuclear Medicine LLC
  • 12.2.14.Jubilant DraxImage Inc.
  • 12.2.15.Sumitomo Heavy Industries, Ltd.
  • 12.2.16.Telix Pharmaceuticals Limited
  • 12.2.17.Others

13.360 Degree Analyst View

14.Appendix

• 14.1.Research Methodology
• 14.2.References
• 14.3.Abbreviations
• 14.4.Disclaimer
• 14.5.Contact Us